Tumor Necrosis Factor-related Weak Inducer of Apoptosis Augments Matrix Metalloproteinase 9 (MMP-9) Production in Skeletal Muscle through the Activation of Nuclear Factor-κB-inducing Kinase and p38 Mitogen-activated Protein Kinase

A POTENTIAL ROLE OF MMP-9 IN MYOPATHY*

  1. Hong Li,
  2. Ashwani Mittal,
  3. Pradyut K. Paul,
  4. Mukesh Kumar,
  5. Daya S. Srivastava,
  6. Suresh C. Tyagi§ and
  7. Ashok Kumar1
  1. Departments of Anatomical Sciences and Neurobiology and §Physiology and Biophysics, University of Louisville School of Medicine, Louisville, Kentucky 40202
  1. 1 To whom correspondence should be addressed. Tel.: 502-852-1133; Fax: 502-852-6228; E-mail: ashok.kumar{at}louisville.edu.

Abstract

Destruction of skeletal muscle extracellular matrix is an important pathological consequence of many diseases involving muscle wasting. However, the underlying mechanisms leading to extracellular matrix breakdown in skeletal muscle tissues remain unknown. Using a microarray approach, we investigated the effect of tumor necrosis factor-related weak inducer of apoptosis (TWEAK), a recently identified muscle-wasting cytokine, on the expression of extracellular proteases in skeletal muscle. Among several other matrix metalloproteinases (MMPs), we found that the expression of MMP-9, a type IV collagenase, was drastically increased in myotubes in response to TWEAK. The level of MMP-9 was also higher in myofibers of TWEAK transgenic mice. TWEAK increased the activation of both classical and alternative nuclear factor-κB (NF-κB) signaling pathways. Inhibition of NF-κB activity blocked the TWEAK-induced production of MMP-9 in myotubes. TWEAK also increased the activation of AP-1, and its inhibition attenuated the TWEAK-induced MMP-9 production. Overexpression of a kinase-dead mutant of NF-κB-inducing kinase or IκB kinase-β but not IκB kinase-α significantly inhibited the TWEAK-induced activation of MMP-9 promoter. The activation of MMP-9 also involved upstream recruitment of TRAF2 and cIAP2 proteins. TWEAK increased the activity of ERK1/2, JNK1, and p38 MAPK. However, the inhibition of only p38 MAPK blocked the TWEAK-induced expression of MMP-9 in myotubes. Furthermore the loss of body and skeletal muscle weights, inflammation, fiber necrosis, and degradation of basement membrane around muscle fibers were significantly attenuated in Mmp9 knock-out mice on chronic administration of TWEAK protein. The study unveils a novel mechanism of skeletal muscle tissue destruction in pathological conditions.

Footnotes

  • 2 The abbreviations used are: MMP, matrix metalloproteinase; AP-1, activator protein-1; cIAP, cellular inhibitor of apoptosis; DM, differentiation medium; DN, dominant negative; EMSA, electrophoretic mobility shift assay; ERK, extracellular signal-regulated kinase; IκB, inhibitor of κB; IKK, IκB kinase; JNK, c-Jun NH2-terminal kinase; MAPK, mitogen-activated protein kinase; NF-κB, nuclear factor-κB; NIK, NF-κB-inducing kinase; SEAP, secreted alkaline phosphatase; TNF, tumor necrosis factor; TRAF, TNF receptor-associated factor; TIMP, tissue inhibitor of metalloproteases; TWEAK, TNF-related weak inducer of apoptosis; NDGA, nordihydroguaiaretic acid; siRNA, short interfering RNA; GST, glutathione S-transferase; TA, tibial anterior.

  • 3 H. Li and A. Kumar, unpublished observation.

  • * This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AG129623 (to A. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • Received July 21, 2008.
    • Revision received November 10, 2008.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement